Analgesic Efficacy of a Combination of Fentanyl and a Japanese Herbal Medicine "Yokukansan" in Rats with Acute Inflammatory Pain.
Yuko AkanumaMami KatoYasunori TakayamaHideshi IkemotoNaoki AdachiYusuke OhashiWakako YogiTakayuki OkumoMana TsukadaMasataka SunagawaPublished in: Medicines (Basel, Switzerland) (2020)
Background: Fentanyl can induce acute opioid tolerance and postoperative hyperalgesia when administered at a single high dose; thus, this study examined the analgesic efficacy of a combination of fentanyl and Yokukansan (YKS). Methods: Rats were divided into control, formalin-injected (FOR), YKS-treated+FOR (YKS), fentanyl-treated+FOR (FEN), and YKS+FEN+FOR (YKS+FEN) groups. Acute pain was induced via subcutaneous injection of formalin into the paw. The time engaged in pain-related behavior was measured. Results: In the early (0-10 min) and intermediate (10-20 min) phases, pain-related behavior in the YKS+FEN group was significantly inhibited compared with the FOR group. In the late phase (20-60 min), pain-related behavior in the FEN group was the longest and significantly increased compared with the YKS group. We explored the influence on the extracellular signal-regulated kinase (ERK) pathway in the spinal cord, and YKS suppressed the phosphorylated ERK expression, which may be related to the analgesic effect of YKS in the late phase. Conclusions: These findings suggest that YKS could reduce the use of fentanyl and combined use of YKS and fentanyl is considered clinically useful.
Keyphrases
- neuropathic pain
- chronic pain
- spinal cord
- pain management
- liver failure
- drug induced
- spinal cord injury
- high dose
- respiratory failure
- cell proliferation
- signaling pathway
- low dose
- poor prognosis
- hepatitis b virus
- oxidative stress
- transcription factor
- postoperative pain
- newly diagnosed
- acute respiratory distress syndrome
- binding protein